SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

PHIA

24.26

+0.96%↑

SRT3

241.7

-2.89%↓

ORNBV.FI

52.44

-0.19%↓

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

PHIA

24.26

+0.96%↑

SRT3

241.7

-2.89%↓

ORNBV.FI

52.44

-0.19%↓

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

PHIA

24.26

+0.96%↑

SRT3

241.7

-2.89%↓

ORNBV.FI

52.44

-0.19%↓

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

PHIA

24.26

+0.96%↑

SRT3

241.7

-2.89%↓

ORNBV.FI

52.44

-0.19%↓

SAN

103.98

+0.48%↑

SHL.DE

55.4

+0.54%↑

PHIA

24.26

+0.96%↑

SRT3

241.7

-2.89%↓

ORNBV.FI

52.44

-0.19%↓

Search

Merck KGaA

Closed

135.5 -0.7

Overview

Share price change

24h

Current

Min

135.1

Max

135.65

Key metrics

By Trading Economics

Income

202M

809M

Sales

-194M

5.3B

P/E

Sector Avg

26.27

73.394

EPS

2.2

Dividend yield

1.34

Profit margin

15.363

EBITDA

85M

1.6B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+30.26 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.34%

3.09%

Next Earnings

6 Mar 2025

Market Stats

By TradingEconomics

Market Cap

33B

98B

Previous open

136.2

Previous close

135.5

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

Merck KGaA Chart

Past performance is not a reliable indicator of future results.

Related News

11 Feb 2025, 07:03 UTC

Acquisitions, Mergers, Takeovers

Germany's Merck in Talks to Buy SpringWorks Therapeutics

10 Feb 2025, 16:38 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

SpringWorks Therapeutics Shares Rise on Report it May be Acquired

14 Nov 2024, 08:09 UTC

Earnings

Merck KGaA Earnings Growth Beats Expectations -- Update

14 Nov 2024, 06:26 UTC

Earnings

Merck KGaA Expects Sales at Lower End of Outlook Range After Third-Quarter Miss

11 Feb 2025, 16:45 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk

11 Feb 2025, 10:54 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk

11 Feb 2025, 10:52 UTC

Market Talk
Acquisitions, Mergers, Takeovers

German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk

6 Jan 2025, 13:08 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Transaction closed on Dec. 23, 2024

6 Jan 2025, 13:07 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: Didn't Disclose Financial Details

6 Jan 2025, 13:06 UTC

Acquisitions, Mergers, Takeovers

Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio

6 Jan 2025, 13:04 UTC

Acquisitions, Mergers, Takeovers

Merck KaA Acquires HUB Organoids Holding B.V. to Expand Its Next-Generation Biology Portfolio

17 Dec 2024, 13:05 UTC

Acquisitions, Mergers, Takeovers

Merck: Deal Expected to Close By End Dec. 2024

17 Dec 2024, 13:04 UTC

Acquisitions, Mergers, Takeovers

Merck: Terms of Deal Undisclosed

17 Dec 2024, 13:04 UTC

Acquisitions, Mergers, Takeovers

Merck Signs Pact to Buy HUB Organoids

17 Dec 2024, 13:03 UTC

Acquisitions, Mergers, Takeovers

Merck: Acquisition Advances Next Gen Biology Portfolio

17 Dec 2024, 13:03 UTC

Acquisitions, Mergers, Takeovers

Merck to Buy HUB Organoids Holding

14 Nov 2024, 11:15 UTC

Market Talk

Merck KGaA's Sales Target Dragged by Muted China Outlook -- Market Talk

14 Nov 2024, 10:45 UTC

Market Talk
Earnings

Merck KGaA's Life-Science Sales Recovery Is Encouraging -- Market Talk

14 Nov 2024, 09:26 UTC

Market Talk
Earnings

Merck KGaA's Electronics Division Disappointed -- Market Talk

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Sees 2024 EBITDA Before One-Time Items Around Mid-Point Of Range

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Had Seen 2024 Net Sales Between EUR20.7B and EUR22.1B

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA 3Q EBITDA EUR1.55B .

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Sees 2024 EPS Pre Around Mid-Point of EUR8.20 to EUR9.30

14 Nov 2024, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 3Q Ebitda Before One-Time Items at EUR1.55B

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Backs 2024 View

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA 3Q Sales EUR5.27B

14 Nov 2024, 06:00 UTC

Earnings

Analysts Saw Merck KGaA 3Q Net Sales at EUR5.33B

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA: 3Q Life Science Returns to Organic Sales Growth

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Had Seen 2024 EBITDA Before One-Time Items Between EUR5.8B to EUR6.4B

14 Nov 2024, 06:00 UTC

Earnings

Merck KGaA Expects 2024 Net Sales In Lower Half Of Range

Peer Comparison

Price change

Merck KGaA Forecast

Price Target

By TipRanks

30.26% upside

12 Months Forecast

Average 176.5 EUR  30.26%

High 190 EUR

Low 160 EUR

Based on 8 Wall Street analysts offering 12 month price targets forMerck KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

134.7 / 135.55Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Merck KGaA

There is no Profile data available for MRK.BE.